Vitamin K-Dependent Carboxylase: Increased Efficiency of the Carboxylation Reaction

Summary

The in vitro vitamin K-dependent carboxylation of peptide- or protein-bound glutamate residues is generally studied in detergent-solubilized microsomes from rat or cow liver. Under the conditions usually employed, the efficiency of the carboxylation reaction is low (less than 1% of the carboxylatable residues is converted into gammacarboxyglutamate). Here we describe that this efficiency may be raised to 30% by carrying out the following adaptations: 1) carboxylase was purified about 100-fold from the solubilized microsomes, so that the enzyme was obtained in a highly concentrated form and could be added in excess; 2) the HCO^- ₃ concentration in the reaction mixtures was raised to 50 mM and 3) a substrate was selected (decarboxylated osteocalcin from bovine bone) the K_m of which had been shown to be low (10 pM) and it was added in rate-limiting amounts. Besides the fact that under these conditions the carboxylation reaction occurred with a higher efficiency than before, the adaptations also enabled us to express the carboxylation activity in terms of moles CO₂ incorporated per mole of substrate.

Keywords

Vitamin K - Carboxylase - Gammacarboxyglutamic acid - Blood coagulation - Warfarin

• References

• 1 Olson RE. The function and metabolism of vitamin K. Ann Rev Nutr 1984; 4: 281-337
• 2 Suttie JW, Preusch PC. Studies on the vitamin K-dependent carboxylase and vitamin K epoxide reductase in rat liver. Haemostasis 1986; 16: 193-215
• 3 Vermeer C, de Boer-van den Berg M AG. Vitamin K-dependent carboxylase. Haematologia 1985; 18: 71-97
• 4 De Metz M, Vermeer C, Soute B AM, van Scharrenburg G JM, Slotboom AJ, Hemker HC. Partial purification of bovine liver vitamin K-dependent carboxylase onto antifactor X. FEBS Lett 1981; 123: 215-218
• 5 Pan LC, Williamson MK, Price PA. Sequence of the precursor to rat bone gamma-carboxyglutamic acid protein that accumulates in warfarin-treated osteosarcoma cells. J Biol Chem 1985; 260: 13398-13401
• 6 Soute B AM, Miiller-Esterl W, de Boer-van den Berg M AG, Ulrich M MW, Vermeer C. Vitamin K-dependent proteins in testes and in spermatozoa. FEBS Lett 1985; 190: 137-141
• 7 De Metz M, Soute B AM, Hemker HC. Stimulation of the vitamin K-dependent carboxylase from bovine liver. Biochem J 1983; 209: 719-724
• 8 Vermeer C, Soute B AM, Hendrix H, de Boer-van den Berg M AG. Decarboxylated bone. Gla-protein as a substrate for hepatic vitamin K-dependent carboxylase. FEBS Lett 1984; 165: 16-20
• 9 Vermeer C, Soute B AM, Ulrich M MW, van de Loo P GF. Vitamin K and the urogenital tract. Haemostasis 1986; 16: 246-257
• 10 De Metz M, Vermeer C, Soute B AM, Hemker HC. Identification of phospholipid as an essential part of bovine vitamin K-dependent carboxylase. J Biol Chem 1981; 256: 10843-10846
• 11 Sedmak JJ, Grossberg SE. A rapid sensitive and versatile assay for protein using Coomassie brilliant blue G250. Anal Biochem 1977; 79: 544-552
• 12 Kuwada M, Katayama K. An improved method for the determination of gammacarboxyglutamic acid in proteins, bone and urine. Anal Biochem 1983; 131: 173-179
• 13 Canfield LM, Sinsky TA, Suttie JW. Vitamin K-dependent carboxylase: purification of the rat liver microsomal enzyme. Arch Biochem Biophys 1980; 202: 515-524
• 14 Vermeer C, Soute B AM, de Metz M, Hemker HC. A comparison between vitamin K-dependent carboxylase from normal and warfarintreated cows. Biochim Biophys Acta 1982; 714: 361-365
• 15 De Boer-van den Berg M AG, Thijssen H HW, Vermeer C. The in vivo effects of acenocoumarol, phenprocoumon and warfarin on vitamin K-dependent carboxylase in various tissues of the rat. Biochim Biophys Acta 1986; 884: 150-157
• 16 De Boer-van den Berg M AG, Soute B AM, Ulrich M MW, Hemker HC, Vermeer C. Vitamin K-dependent carboxylase: the carboxylation of exogenous substrates in different systems. Biochim Biophys Acta 1985; 831: 94-98
• 17 Larson AE, Friedman PA, Suttie JW. Vitamin K-dependent carboxylase. Stoichiometry of carboxylation and vitamin K 2,3-epoxide formation. J Biol Chem 1981; 256: 11032-11035
• 18 Fung MR, Hay CW, MacGillivray R TA. Characterization of an almost full-length cDNA for human blood coagulation factor X. Proc Natl Acad Sci USA 1985; 82: 3591-3595
• 19 Kurachi K, Davie EW. Isolation and characterization of a cDNA coding for human factor IX. Proc Natl Acad Sci USA 1982; 79: 6461-6464
• 20 Degen S JF, MacGillivray R TA, Davie EW. Characterization of the complementary deoxyribonucleic acid and gene coding for human prothrombin. Biochemistry 1983; 22: 2087-2097
• 21 Foster DC, Yoshitake S, Davie EW. The nucleotide sequence of the gene for human protein C. Proc Natl Acad Sci USA 1985; 82: 4673-4677
• 22 De la Salle H, Altenburger W, Elkaim R, Dott K, Dieterle A, Drillieu R, Cazenave JP, Tolstoshev P, Lecocq JP. Active gammacarboxylated human factor IX expressed using recombinant DNA techniques. Nature 1985; 316: 268-270
• 23 Busby S, Kumar A, Joseph M, Halfpap L, Insley M, Berkner K, Kurachi K, Woodbury R. Expression of active human factor IX in transfected cells. Nature 1985; 316: 271-273
• 24 Kaufman RJ, Wasley LC, Furie BC, Furie B, Shoemaker CB. Expression, purification and characterization of recombinant gammacarboxylated factor IX synthesized in Chinese hamster ovary cells. J Biol Chem 1986; 261: 9622-9628